Not admitted · Not a forecast
Rules 1.1.0 · as of 14 Sep 2026
Rick Doblin · Said 25 Aug 2021 · doblin-0154
Quote
Not a forecast
“If MAPS' wholly owned pharmaceutical arm, the MAPS Public Benefit Corporation (MAPS PBC), was publicly traded, it would probably have a market cap in the range of or exceeding these other companies.”
Vol. 31 No. 2 column. Hypothetical valuation of MAPS PBC compared with publicly traded psychedelic companies with market caps above $1.35 billion.
Descriptive, retrospective, or a statement of preference; no future state asserted.